Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-550-1 | CAS number: 108-10-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1984
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Referenceopen allclose all
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
- Reference Type:
- publication
- Title:
- Mutagenicity studies on ketone solvents: methyl ethyl ketone, methyl isobutyl ketone and isophorone
- Author:
- O'donoghue JL, Haworth SR, Curren RD, Kirby PE., Lawlor T et al.
- Year:
- 1 988
- Bibliographic source:
- Mutat. Res., 206, 149-161
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- 4-methylpentan-2-one
- EC Number:
- 203-550-1
- EC Name:
- 4-methylpentan-2-one
- Cas Number:
- 108-10-1
- Molecular formula:
- C6H12O
- IUPAC Name:
- 4-methylpentan-2-one
- Details on test material:
- - Name of test material (as cited in study report): Methyl Isobutyl Ketone
- Physical state: Liquid in amber bottle; color not determined
- Storage condition of test material: Room temperature under nitrogen
Constituent 1
Method
- Target gene:
- Thymidine kinase
Species / strain
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Aroclor-induced rat liver microsomes (S9)
- Test concentrations with justification for top dose:
- 0.6, 1.4, 2.1, 2.9, or 3.7 µL/mL (-S9) and 1.4, 1.9, 2.5, 3.0, or 3.4 µL/mL (+S9).
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: Ethylmethanesulfonate (-S9) and 7,12-Dimethylbenzanthracene (+S9)
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 4 hours at 37 ºC
- Expression time (cells in growth medium): 2 days with a cell population adjustment at 24 and 48 hours
NUMBER OF REPLICATIONS: Duplicate (no repeat experiment performed). - Evaluation criteria:
- The following criteria were used as guidelines in judging the significance of the activity of a test article in this system. In evaluating the results, it is considered that increases in mutant frequencies, which occur only at highly toxic concentrations, may be due to epigenetic events. Unfortunately, it is impossible to formulate criteria which would apply to all types of data which may be generated and therefore the scientist’s evaluation must be the final endpoint.
Positive:- if there is a positive dose response and one or more of the three highest doses exhibit a mutant frequency which is two-fold greater than the background level.
Equivocal:- if there is no dose response but any one or more doses exhibit a two-fold increase in mutant frequency over background.
Negative:- if there is no dose response and none of the test cultures exhibit mutant frequencies which are two-fold greater than background.
Note:
1. Some of the numbers generated by the test data, whether it is toxicity, mutant frequency, etc., are computed using non-rounded numbers. This may, in some instances, cause what appear to be errors in calculation if only the rounded numbers are used when checking the data.
2. All of the raw data generated by the assay and the original final report will be maintained in Microbiological Associates’ archives located in our Bethesda, Maryland facilities.
3. The stability of the test article under the actual experimental conditions used in this study was not determined by Microbiological Associates.
4. All test article stock solutions were freshly prepared immediately before their use in each procedure. - Statistics:
- Not performed (number of revertant colonies were counted)
Results and discussion
Test results
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- other: (-S9) = equivocal (defined in the study report as the absence of a dose-response relationship, but the presence of a two-fold increase in mutant frequency over background at any of the doses examined) and (+S9) = negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Chemical Manufacturers Association’s test article, methyl isobutyl ketone was tested in the L5178Y TK+/- Mouse Lymphoma Mutagenesis Assay in the presence and absence of Aroclor induced rat liver S-9. Four mutagenesis assays were conducted. However, there were technical difficulties with three of the assays and the results were not provided in the study report. In the fourth assay, four non-activated cultures (-S9) that were cloned exhibited mutant frequencies which were more than twice the mean mutant frequency of the solvent controls. No clear dose-dependent response was noted in the cultures. None of the S9 activated cultures that were cloned exhibited mutant frequencies which were significantly greater than the mean mutant frequency of the solvent controls.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
ambiguous without metabolic activation
negative with metabolic activation - Executive summary:
In a non-GLP mammalian gene mutation assay (equivalent to OECD guideline 476), MIBK was tested at doses of 0, 0.6, 1.4, 2.1, 2.9, or 3.7 µL/mL in the absence of exogenous metabolic activation (Aroclor 1254-induced rat liver S9) and at doses of 0, 1.4, 1.9, 2.5, 3.0, or 3.4 µL/mLin the presence of exogenous metabolic activation in mouse lymphoma L5178Y cells. The experiment was conducted in duplicate; however, an independent repeat experiment was not performed. DMSO was used as the vehicle and ethylmethanesulfonate and 7,12-dimethylbenzanthracene were used as the positive control compounds in the absence and presence of metabolic activation, respectively. No cytotoxicity and no increase in the mutant frequency were observed at any MIBK concentration in the presence of metabolic activation. Cytotoxicity and equivocal genotoxicity (defined as a two-fold increase in the mutation frequency over solvent control levels at one or more dose levels but the absence of a dose-response) were noted at 3.7 µL/mL (the highest concentration tested) in the absence of metabolic activation. Incubation with positive control substances in the presence or absence of metabolic activation resulted in anticipated increases in the mutation frequencies.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.